Efficacy and safety of electrical cardioversion in atrial fibrillation in respect to antithrombotic therapy approaches
https://doi.org/10.29001/2073-8552-2015-30-1-66-70
Abstract
The article discusses strategies of management of patients with atrial fibrillation (AF): control of cardiac rhythm or heart rate (HR). Based on own data from over 10-year-old experience with cardioversion performed in Novosibirsk Regional Clinical Cardiology Dispensary, the algorithm of management of a patient is presented; the preparation and method for electronic cardioversion are described. The article analyses the results of external shock therapy (EST) and complications from the use of various anticoagulants for the safe restoration of sinus rhythm. Authors make conclusions on the preferability of cardiac rhythm control strategy in patients with atrial fibrillation and on the safety and efficacy of electrical cardioversion in the presence of adequate antithrombotic support.
About the Authors
S. A. Zenin
Novosibirsk Regional Clinical Cardiology Dispensary
Russian Federation
Russian Federation
A. V. Fedoseenko
Novosibirsk Regional Clinical Cardiology Dispensary
Russian Federation
Russian Federation
O. V. Konenko
Novosibirsk Regional Clinical Cardiology Dispensary
Russian Federation
Russian Federation
O. V. Pyataeva
Novosibirsk Regional Clinical Cardiology Dispensary
Russian Federation
Russian Federation
I. V. Polyakova
Novosibirsk Regional Clinical Cardiology Dispensary
Russian Federation
Russian Federation
References
1. Бокерия Л.А., Ревишвили А.Ш., Голицын С.П. Клинические рекомендации по проведению электрофизиологических исследований катетерной аблации и применению имплантируемых антиаритмических устройств. ВНОА. - 3-е изд., доп. и перераб. - М.: Макс Пресс, 2013. - 596 с.
2. Stewart S., Hart C.L., Hole D.J. et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew / Paisley study // Heart. - 2001. - Vol. 86. - P. 516-521.
3. Miyasaka Y., Barnes M.E., Gersh B.J. et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence // Circulation. - 2006. - Vol. 114. - P. 119-125.
4. Naccarelli G.V., Varker H., Lin J. et al. Increasing prevalence of atrial fibrillation and flutter in the United States // Am. J. Cardiol. - 2009. - Vol. 104. - P. 1534-1539.
5. Friberg L., Hammar N., Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation // Eur. Heart J. - 2010. - Vol. 31. - P. 967-975.
6. Heeringa J., van der Kuip D.A., Hofman A. et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study // Eur. Heart J. - 2006. - Vol. 27. - P. 949-953.
7. Stewart S., Hart C.L., Hole D.J. et al. A population-based study of the long-term risks associated with atrial fibrillation: 20- year follow-up of the Renfrew / Paisley study // Am. J. Med. - 2002. - Vol. 113. - P. 359-364.
8. Hylek E.M., Go A.S., Chang Y. et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation // N. Engl. J. Med. - 2003. - Vol. 349. - P. 10191026.
9. Thrall G., Lane D., Carroll D. et al. Quality of life in patients with atrial fibrillation: a systematic review // Am. J. Med. - 2006. -Vol. 119. - P. 448e1-e19.
10. AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation // N. Engl. J. Med. -2002. - Vol. 347. - P. 1825-1833.
11. Van Gelder I.C., Hagens V.E., Bosker H.A. et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation // N. Engl. J. Med. - 2002. -Vol. 347. - P. 1834-1840.
12. Roy D., Talajic M., Nattel S. et al. Rhythm control versus rate control for atrial fibrillation and heart failure // N. Engl. J. Med. - 2008. - Vol. 358. - P. 2667-2677.
13. Hsu L.F., Jais P., Sanders P. et al. Catheter ablation for atrial fibrillation in congestive heart failure // N. Engl. J. Med. - 2004. - Vol. 351. - P. 2373-2383.
14. Khan M.N., Jais P., Cummings J. et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure // N. Engl. J. Med. - 2008. - Vol. 359. - P. 1778-1785.
15. Berge E. et al. Outcomes after rhythm versus rate control in patients with atrial fibrillation: the international prospective GARFIELD registry // Eur. Heart J. - 2013. - Vol. 34, suppl. 1. -P. 551.
16. Функциональное состояние больных с фибрилляцией предсердий. Данные исследования AFFIRM [Электронный ресурс]. - URL: http://www.medmir.com/content/view/705/9 (дата обращения 15.02.2015).
17. Ezekowitz M.D., Cappato R. Klein A.L., Camm A.J. et al. Rationale and design of the eXplore the efficacy and safety of once-daily oral rivaroxaban for the prevention of cardiovascular events in patients with nonvalvular atrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion // Am. Heart J. - 2014. - Vol. 167(5). - P. 646-652.
18. Татарский Б.А., Нефедова Н.В. Электрическая наружная кардиоверсия при лечении пароксизмальной фибрилляции предсердий // Вестник аритмологии. - 2000. - № 19. - С. 95-99.
19. Попов С.В., Аубакирова Г.А., Антонченко И.В. и др. Эффективность антиаритмического препарата III класса нибентана у больных с фибрилляцией предсердий // Вестник аритмологии. - 2003. - № 31. - С. 10-14.
20. Востриков В.А. Эффективность и безопасность электроимпульсной терапии фибрилляции предсердий // Методы нелинейного анализа в кардиологии и онкологии / под ред. Р.З. Назирова. - М.: Университет, 2010. - С. 73-79.
21. Антитромботическая терапия при мерцательной аритмии: учебно-методическое пособие / под ред. проф. Б.А. Сидоренко. - М., 2010. - С. 46-47.
Review
For citations:
Zenin S.A., Fedoseenko A.V., Konenko O.V., Pyataeva O.V., Polyakova I.V. Efficacy and safety of electrical cardioversion in atrial fibrillation in respect to antithrombotic therapy approaches. Siberian Journal of Clinical and Experimental Medicine. 2015;30(1):66-70. (In Russ.) https://doi.org/10.29001/2073-8552-2015-30-1-66-70
Views:
839
.png)
Email this article 